Repository logo
 
Publication

Use of MALDI-TOF Mass Spectrometry to Assay the Transthyretin V30M Mutation in Serum From a Liver Transplant Donor

dc.contributor.authorLacerda, Pedro C.
dc.contributor.authorMoreira, Luciana
dc.contributor.authorVitorino, Rui
dc.contributor.authorCosta, Paulo P.
dc.date.accessioned2016-02-15T12:37:33Z
dc.date.available2016-02-15T12:37:33Z
dc.date.issued2015-05
dc.description.abstractFamilial amyloidotic polyneuropathy (FAP), Portuguese type, or ATTR V30M is an autosomal dominant inherited disorder caused by a mutation in the transthyretin gene, with a valine/methionine substitution at position 30 (TTRV30M). ATTRV30Mis characterized by a progressive sensory/autonomic polyneuropathy and multiple organ dysfunction. Liver transplantation is the main therapeutic option,as it virtually eliminates the production of circulating TTR V30M, which occurs predominantly in the liver.
dc.description.sponsorshipThis work was supported by Portuguese Foundation for Science and Technology (FCT), European Union, QREN, FEDER and COMPETE for funding the QOPNA research unit (project PEst-C/QUI/UI0062/2013), RNEM (Portuguese Mass Spectrometry Network) and COST action BM1305. It was also funded by Instituto Nacional de Saúde Dr. Ricardo Jorge, INSA I.P., Portugal.pt_PT
dc.identifier.citationTransplantation. 2015 May;99(5):e33-4. doi: 10.1097/TP.0000000000000658.pt_PT
dc.identifier.doi10.1097/TP.0000000000000658pt_PT
dc.identifier.issn0041-1337
dc.identifier.urihttp://hdl.handle.net/10400.18/3295
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherLippincott, Williams & Wilkins/ Transplantation Societypt_PT
dc.relation.publisherversionhttp://journals.lww.com/transplantjournal/Citation/2015/05000/Use_of_MALDI_TOF_Mass_Spectrometry_to_Assay_the.34.aspxpt_PT
dc.subjectHereditary Amyloidosispt_PT
dc.subjectATTR Amyloidosispt_PT
dc.subjectTTR V30Mpt_PT
dc.subjectMass Spectrometrypt_PT
dc.subjectMALDI-TOFpt_PT
dc.subjectMolecular biologypt_PT
dc.subjectTransplantation surgerypt_PT
dc.subjectDoenças Genéticas
dc.subjectDeterminantes da Saúde e da Doença
dc.titleUse of MALDI-TOF Mass Spectrometry to Assay the Transthyretin V30M Mutation in Serum From a Liver Transplant Donorpt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/COMPETE/PEst-C%2FQUI%2FUI0062%2F2013/PT
oaire.citation.endPagee34pt_PT
oaire.citation.startPagee33pt_PT
oaire.citation.titleTransplantationpt_PT
oaire.citation.volume99(5)pt_PT
oaire.fundingStreamCOMPETE
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
rcaap.rightsembargoedAccesspt_PT
rcaap.typearticlept_PT
relation.isProjectOfPublicationcefc5003-39e1-47fb-9a4d-188116bfe083
relation.isProjectOfPublication.latestForDiscoverycefc5003-39e1-47fb-9a4d-188116bfe083

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Lacerda 2015 - Use of MALDI-TOF Mass Spectrometry to Assay the Transthyretin V30M Mutation in Serum From a Liver Transplant Donor...pdf
Size:
247.9 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: